In vitro and in vivo suppression of hepatocellular carcinoma growth by midkine-antisense oligonucleotide-loaded nanoparticles

被引:23
作者
Dai, Li-Cheng [1 ]
Yao, Xing [2 ]
Wang, Xiang [1 ]
Niu, Shu-Qiong [1 ]
Zhou, Lin-Fu [3 ]
Fu, Fang-Fang [3 ]
Yang, Shui-Xin [1 ]
Ping, Jin-Liang [4 ]
机构
[1] Huzhou Cent Hosp, Huzhou Key Lab Mol Med, Huzhou 313000, Zhejiang, Peoples R China
[2] Huzhou Cent Hosp, Dept Gen Surg, Huzhou 313000, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sch Med, Hangzhou 310016, Zhejiang, Peoples R China
[4] Huzhou Cent Hosp, Dept Pathol, Huzhou 313000, Zhejiang, Peoples R China
关键词
Midkine; Nanoparticles; Hepatocellular carcinoma; Inhibition; Drug delivery; TUMOR-GROWTH; EXPRESSION; CANCER; DIFFERENTIATION; PLEIOTROPHIN;
D O I
10.3748/wjg.15.1966
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To synthesize antisense oligonucleotides (ASODNs) of midkine (MK), package the ASODNs with nanoparticles, and to inhibit hepatocellular carcinoma (HCC) growth using these nanoparticles. METHODS: HepG2 cell proliferation was analyzed in vitro using the 3-(4,5-dimethythiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)- 2Htetrazolium, inner salt assay. The in vivo activity of nanoparticles delivering the MK-ASODNs was analyzed by histopathological and immunohistochemical staining and quantitative real time polymerase chain reaction (PCR). RESULTS: The in vitro proliferation of HepG2 cells was significantly inhibited by the nanoparticles packaged with MK-ASODNs (NANO-ASODNs). Furthermore, the NANO-ASODNs significantly inhibited the growth of HCC in the mouse model. CONCLUSION: NANO-ASODNs can significantly suppress the growth of HCC in vitro and in vivo. (C) 2009 The WJG Press and Baishideng. All rights reserved.
引用
收藏
页码:1966 / 1972
页数:7
相关论文
共 23 条
[1]   INCREASED MIDKINE GENE-EXPRESSION IN HUMAN GASTROINTESTINAL CANCERS [J].
ARIDOME, K ;
TSUTSUI, J ;
TAKAO, S ;
KADOMATSU, K ;
OZAWA, M ;
AIKOU, T ;
MURAMATSU, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (07) :655-661
[2]   Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts [J].
Banno, Hiroshi ;
Takei, Yoshifumi ;
Muramatsu, Takashi ;
Komori, Kimihiro ;
Kadomatsu, Kenji .
JOURNAL OF VASCULAR SURGERY, 2006, 44 (03) :633-641
[3]   Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery [J].
Dai, Hui ;
Jiang, Xuan ;
Tan, Geoffrey Cy ;
Chen, Yong ;
Torbenson, Michael ;
Leong, Kam W. ;
Mao, Hai-Quan .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (04) :507-522
[4]   RETRACTED: Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model (Retracted article. See vol. 40, pg. 1502, 2019) [J].
Dai, Li-cheng ;
Wang, Xiang ;
Yao, Xing ;
Min, Li-shan ;
Ping, Jin-liang ;
He, Jian-fang .
ACTA PHARMACOLOGICA SINICA, 2007, 28 (03) :453-458
[5]   RETRACTED: Antisense oligonucleotides targeting midkine induced apoptosis and increased chemosensitivity in hepatocellular carcinoma cells (Retracted article. See vol. 40, pg. 1501, 2019) [J].
Dai, Li-Cheng ;
Wang, Xiang ;
Yao, Xing ;
Lu, Yong-Liang ;
Ping, Jin-Liang ;
He, Jian-Fang .
ACTA PHARMACOLOGICA SINICA, 2006, 27 (12) :1630-1636
[6]   Formation and intracellular trafficking of lipoplexes and polyplexes [J].
Elouahabi, A ;
Ruysschaert, JM .
MOLECULAR THERAPY, 2005, 11 (03) :336-347
[7]  
GARVER RI, 1994, CANCER, V74, P1584, DOI 10.1002/1097-0142(19940901)74:5<1584::AID-CNCR2820740514>3.0.CO
[8]  
2-V
[9]  
Johnson P J, 2001, Clin Liver Dis, V5, P145, DOI 10.1016/S1089-3261(05)70158-6
[10]   Immunohistochemical analysis of Midkine expression in human prostate carcinoma [J].
Konishi, N ;
Nakamura, M ;
Nakaoka, S ;
Hiasa, Y ;
Cho, M ;
Uemura, H ;
Hirao, Y ;
Muramatsu, T ;
Kadomatsu, K .
ONCOLOGY, 1999, 57 (03) :253-257